Press Trust of India / Mumbai Jan 05, 2010, 21:01 IST
Life Sciences technology firm, Opto Circuits, a wholly-owned subsidiary Eurocor has received Communite European (CE) approval to market and sale its Drug Eluting Stent- Taxcor Plus in the world markets.
"Taxcor Plus is backed by years of research and has shown excellent clinical results," Opto Circuits Chairman & Managing Director Vinod Ramnani said.